The primary indication for lung transplantation is irreversible end-stage pulmonary disease expected to result in death within 1to 2 years and for which there are no other treatment options. Clinical conditions for which lung transplantation is indicated include the following:

1. Obstructive lung disease/Emphysema

Chronic obstructive pulmonary disease (COPD)

Alpha-1-antitrypsin deficiency

2. Restrictive lung disease

Idiopathic pulmonary fibrosis (IPF)

3. Pulmonary vascular disease

Primary pulmonary hypertension (PPH)

Eisenmenger's syndrome (ES)

4. Septic lung disease

Cystic fibrosis (CF)

Other "miscellaneous" causes of end-stage lung disease that have been treated with lung transplantation include cystic lung diseases such as sarcoidosis, lymphangioleiomyomatosis, and histiocytosis-X; chemotherapy or radiation therapy induced pulmonary fibrosis, idiopathic bronchiectasis, and obliterative bronchiolitis (OB) as a manifestation of chronic rejection following lung transplantation. The leading indications for lung transplantation between 1995 and 2001 were COPD (39.4%), IPF (16.9%), CF (16.1%), alpha-1-antitrypsin deficiency emphysema (9.3%) and PPH (4.6%).1

Reducing Blood Pressure Naturally

Reducing Blood Pressure Naturally

Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.

Get My Free Ebook

Post a comment